The activation of JAK2 and the resulting dimerization of P-STAT3 regulate gene expressions, such as Bcl2, cyclinD, survivin, and XIAP, which causes cancer cell proliferation and resistance to anticancer drugs [57,58]. This evidence concerns the gene JAK2 and cancer.